Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: James LaFrance, Thomas McLain

Premium

Vermillion has appointed James LaFrance, chairman of the firms' board of directors, to succeed Thomas McLain as president and CEO.

LaFrance, who will continue to serve as Vermillion's board chairman, formerly was CEO of Omnyx. He also held executive leadership posts at Ventana Medical Systems and Bayer Diagnostics.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.